Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Three-Period Crossover Study to Determine the Bioequivalence of Two Oral Formulations Containing Nitisinone 10 mg Compared to Reference Formulation Orfadin In Healthy Subjects Under Fasting Conditions

NCT02750345 is registered in ClinicalTrials.gov with Cycle Pharmaceuticals Ltd. as lead sponsor.

NCT NCT02750345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02750345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Three-Period Crossover Study to Determine the Bioequivalence of Two Oral Formulations Containing Nitisinone 10 mg Compared to Reference Formulation Orfadin In Healthy Subjects Under Fasting Conditions
Lead sponsor
Cycle Pharmaceuticals Ltd.
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2016
Completion date
May 31, 2016
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hereditary tyrosinemia, type i